Time Schedule
Tuesday, 10th April 2012 07:00 – 08:00: Breakfast / Registration / 08:00 – 08:25: Acute Coronary Syndrome Management: Current Challenges and Emerging Solutions / 08:25 – 08:50: Drug Eluting Stent: An Update on Clinical Data / 08:50 – 09:15: Antiplatelet Strategies in Acute Coronary Syndrome: Expanding Choices / 09:15 – 09:25: Discussion / 09:25 – 10:00: Official Opening Ceremony / 10:00 – 10:25: Anticoagulant in ACS and Beyond / 10:25 – 10:50: Newer Antiplatelet: Confronting the Limitations of Antiplatelet Therapy / 10:50 – 11:15: Risk of Bleeding: Balancing Risk and Benefit / 11:15 – 11:25: Discussion / 11:25 – 11:35: Break / 11:35 – 12:00: Heart Failure: Current Medical Therapy / 12:00 – 12:25: Heart Rate as a Therapeutic Target in Heart Failure Patients / 12:25 – 12:50: Devices and Technology in the Management of Heart Failure / 12:50 – 13:00: Discussion / 13:00 – 14:00: Prayer Time, Lunch Break, Exhibition / 14:00 – 14:25: Update on Hypertension Management / 14:25 – 14:50: JNC 8 (VIII): What new is going to be in the guidelines? / 14:50 – 15:15: Strategies for the Management of Resistant Hypertension / 15:15-15:25: Discussion / 15:25-15:40: Break, Prayer Time / 15:40 – 16:05: Medication safety concerns in the cardiovascular patient / 16:05 – 16:30: Lipid management: Optimizing Therapies Old and New / 16:30 – 16:55: Primary prevention of cardiovascular disease: Tools and Strategies / 16:55-17:05: Discussion / Wednesday, 11th April 2012 07:00 –08:00: Breakfast / Registration / 08:00 –08:25: Contemporary approach in Atrial Fibrillation Management / 08:25 –08:50: Antithrombotic Therapy in Afib: Defining the future of Oral Anticoagulant Therapy / 08:50 –09:15: Combined Atrial Fibrillation and Heart Failure: Challenges in Pharmacotherapy Management / 09:15 –09:25: Discussion / 09:25 –09:40: Break / 09:40 –10:05: ICU Management of End Stage Heart Failure and Mechanical Circulatory Support Therapy / 10:05 –10:30: Heart Transplant: indication, selection, pre and post op care / 10:30 –10:55: Long Term Management of Heart Transplant and the Pharmacist Role / 10:55 –11:05: Discussion / 11:05 –11:20: Break / 11:20 –11:45: VTE: Acute and Chronic Management / 11:45 –12:10: Contemporary Management of VHD in Various Medical Settings / 12:10 –12:35: Transcatheter Aortic Valve Implantation (TAVI): Highlight on Procedural and Pharmacotherapy Management Implications / 12:35 –12:45: Discussion / 12:45 –14:00: Prayer Time, Lunch Break, Exhibition / 14:00 –14:25: Antiplatelet resistant / un-responsiveness: Genomic Markers and Advanced Testing / 14:25 –14:50: Tailored antiplatelet therapy: Pharmacogenomics or Dynamic Applications / 14:50 –15:15: Women cardiology: Differences in Diagnosis and Management / 15:15-15:25: Discussion / 15:25-15:40: Break, Prayer Time / 15:40 –16:05: Update on Peripheral Arterial Disease (PAD) Management Guidelines / 16:05 –16:30: Reducing Cardiovascular disease globally through combination approaches to prevention: the polypill / 16:30 –16:55: Ectatic Coronary Arteries management :where are we now / 16:55-17:05: Discussion
Slider

Forgot Your Password?

Please enter your username:

Having Problems?

Please feel free to skype us:

My status

Or email us at support@pscc-pharm.com

Sponsors